查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861928

PET-CT扫描仪市场按应用、设备类型、最终用户、服务类型和机架类型划分－2025-2032年全球预测

PET-CT Scanners Market by Application, Device Type, End User, Service Type, Gantry Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，PET-CT 扫描仪市场将成长至 42.7 亿美元，复合年增长率为 5.31%。

关键市场统计数据
基准年 2024 28.2亿美元
预计年份：2025年 29.7亿美元
预测年份 2032 42.7亿美元
复合年增长率 (%) 5.31%

在医疗保健系统中，对PET-CT成像的临床相关性、技术发展以及采购和服务提供影响进行策略性分析。

正子断层扫描-电脑断层扫描（PET-CT）已发展成为功能诊断和解剖诊断的交会点，成为一种重要的影像学技术。它能够同时显示代谢活动和形态细节，为肿瘤学、心臟病学和神经病学等重要临床路径提供支持，同时也为研究和治疗诊断应用提供了支持。除了临床价值之外，PET-CT系统还在重塑医院、诊断中心和研究机构的工作流程、资本投资计画和服务模式。

检测器材料、影像重建演算法和整合软体平台的技术进步提高了影像保真度、扫描速度和定量精度。这些进步，以及人们对新型放射性示踪剂和混合诊断治疗通讯协定日益增长的兴趣，正在重新定义诊断效率和患者吞吐量的预期。因此，相关人员必须应对更为复杂的采购环境，在这个环境中，设备性能、示踪剂生态系统和服务合约相互作用，共同决定临床和经济效益。

在此背景下，策略决策需要从整体观点，涵盖设备架构、机架性能、维护和升级路径以及最终用户的操作需求。后续章节将整合并说明影响技术采纳的变革性变化、贸易政策阻力、市场区隔差异、区域趋势、竞争要务以及领导者可采取的实际步骤。其目标是提供一个系统性的视角，以支持在临床、财务和监管领域做出明智的选择。

检测器创新、人工智慧驱动的软体、不断发展的示踪剂生态系统以及新的部署模式正在共同重塑临床工作流程、采购和服务策略。

PET-CT系统格局正经历多重整合的变革，这些变革正在重塑临床工作流程、供应链和商业化策略。检测器灵敏度和重建技术的快速发展，使得扫描时间得以缩短，病灶检出更加精准，从而显着提升了工作流程效率和诊断信心。同时，软体主导的进步（尤其是人工智慧和定量成像技术）正在提升整合平台的价值，这些平台能够提供决策支援、自动化品管和简化的报告流程。

在营运方面，医疗服务提供者正在评估新的部署模式，力求平衡固定安装与行动/分散式服务，以扩大服务覆盖范围，惠及服务不足的地区，并优化扫描器的运转率。服务合约、远距离诊断和预防性保养计划的日益普及进一步强化了这一转型，旨在确保设备运作并延长使用寿命。同时，示踪生态系统也不断多元化。虽然传统的放射性示踪剂仍是核心，但对非FDG示踪剂和治疗-诊断组合的探索正在加速，这促使设备製造商、放射性药物供应商和临床团队之间进行更紧密的合作。

最后，监管要求和报销框架也在不断发展，以应对品质保证、资料管治和基于价值的医疗服务。这些变化促使供应商和医疗机构优先考虑互操作系统、完善的文件记录和以结果为导向的证据产生。总而言之，这些变革性的变化提升了整合技术服务伙伴关係关係和策略规划在PET-CT能力取得、实施和维护方面的作用。

评估近期关税调整如何改变了诊断影像设备及关键零件的采购经济效益、供应链韧性和筹资策略。

主要经济体关税调整的累积影响正在产生一系列营运和策略效应，相关人员应认真考虑这些效应。诊断影像设备及组件进口关税的提高通常会导致最终用户到岸成本上升，迫使采购团队重新评估总拥有成本 (TCO) 并探索替代筹资策略。由于关税导致部分供应路线不再经济，製造商和供应商可能会考虑加快本地化生产、实现采购来源多元化或重新配置组件采购，以降低贸易壁垒的影响。

除了直接的成本影响外，关税变化还可能导致现有供应链出现摩擦，并延长关键备件和替换模组的前置作业时间。这项风险凸显了服务弹性和库存规划对于依赖快速取得零件以维持临床连续性的医疗服务提供者的重要性。此外，监管合规和海关程序也会增加跨境交易的行政负担，影响合约条款、保固结构和服务等级协议的谈判。

为此，相关人员正在重新评估其筹资策略，优先考虑便于本地组装和维修的模组化设计，并加强与本地分销商和服务供应商的合作。同时，他们优先选择对进口依赖性较低的设备，并利用资金筹措机制来减轻资本支出的影响。总而言之，这些调整显示贸易政策的变化如何影响整个生态系统，进而影响资本投资决策、服务可靠性以及新技术的采用速度。

基于细分市场的洞察，将临床应用、设备类型、最终用户需求、服务模式和机架配置与策略决策连结起来

对产品和服务细分的深入理解对于将技术产品与临床应用案例和医疗机构能力相匹配至关重要。就临床应用而言，心臟科、神经病学和肿瘤学各自有着独特的需求。肿瘤学领域尤其活跃，其差异体现在两种不同的示踪剂选择：一种是基于FDG的影像技术，能够进行广泛的代谢评估；另一种是非FDG示踪剂，则针对特定的生物路径和受体谱。这些应用层面的差异会影响扫描器的选择标准、示踪剂的物流以及影像通讯协定的设计。

设备类型的考量进一步完善了实施决策。固定係统通常适用于高运作的医疗机构，这些机构优先考虑容量和全面的功能，而行动单元则为小型机构的推广计画和共用服务安排提供了灵活性。最终用户的多样性也至关重要。诊断中心优先考虑容量和预约的便捷性，而医院则需要在住院和门诊病人工作流程之间取得平衡，并且可能需要整合电子健康记录 (EHR) 连接。研究机构重视模组化和高阶定量功能。在医院环境中，私立医疗机构往往优先考虑客户体验和附加价值服务协议，而公立医院则专注于成本效益和广泛的覆盖范围。

服务模式的选择——包括安装、维护和升级——决定了设备的长期性能和生命週期成本。预防性维护和系统化的升级规划有助于延长设备的使用寿命并保持影像品质。同时，安装品质会影响初始校准和法规遵循。机架配置（多切面与单切片）会影响空间解析度、扫描时间和与先进重建技术的兼容性。整合这些分割镜头为产品蓝图和服务模式与市场需求的匹配奠定了全面的基础。

美洲、欧洲、中东和非洲以及亚太地区的区域特征将影响不同医疗保健系统的采购趋势、服务模式和追踪物流。

区域趋势导致需求模式和营运考量各异，进而影响相关人员的投资和实施重点。在美洲，医疗系统呈现出多种多样的支付模式和融资方式，大型三级医疗机构往往是先进影像技术的早期采用者。因此，整合的工作流程、强大的服务网络以及与多种放射性示踪剂的兼容性对于支持复杂的肿瘤学、神经病学和心臟影像影像项目至关重要。

欧洲、中东和非洲地区法规环境和采购模式的多样性要求企业采取灵活的商业策略。在一些市场，公共医疗系统优先考虑成本效益高的解决方案和长期维护合同，而私人医疗机构则在差异化服务和快速取得方面竞争。在迴旋加速器产能有限的市场，跨境合作和区域经销伙伴是应对物流挑战和确保示踪剂供应持续性的常用方法。

亚太地区正经历着装机容量和技术应用的快速成长，同时也拥有成熟的卓越中心。大都会圈人口密度高，催生了可扩展解决方案的需求，包括行动部署以扩展服务覆盖范围至週边地区。此外，在地化生产计划以及全球供应商与区域合作伙伴之间的策略联盟，正在影响产品本地化、监管申报时间表和售后服务模式。了解这些区域差异对于使产品和服务部署与当地营运实际情况相符至关重要。

竞争优势正转向结合硬体效能、软体智慧、卓越服务和策略追踪器伙伴关係的平台。

竞争格局日益受到硬体创新、软体生态系统和服务品质三者交互作用的影响。领先的供应商正在寻求将平台功能与可扩展的软体解决方案相结合的策略，以实现定量成像、工作流程自动化和远距离诊断。与放射性药物供应商和研究机构的合作正成为差异化价值提案的核心，从而能够提供客製化的示踪剂支持计画和临床证据，进而增强诊断定位。

服务和售后产品已成为收入成长和差异化的关键驱动因素。延长保固期、基于绩效的服务合约和远端监控功能旨在减少停机时间，并为服务提供者带来可预测的生命週期经济效益。同时，模组化硬体架构和升级路径使供应商能够在不更换整个系统的情况下，透过提供渐进式改进来维护与现有客户的关係。

从合资企业到区域生产和分销协议，各种合作商业化模式正在帮助供应商应对目标市场的关税风险和监管复杂性。同时，一些公司正在投资临床团队的培训和认证项目，以支援先进的通讯协定和新型示踪剂，从而加速临床应用。这些策略倡议预示着一个新时代的到来：将卓越技术与深厚的服务、对监管的深刻理解以及临床合作相结合的解决方案，将决定竞争优势。

为製造商、供应商和经销商提供切实可行的优先建议，以增强供应韧性、提升服务价值并加速PET-CT技术的临床应用。

为了兼顾临床影响和商业性价值，产业领导者应采取切实可行的优先行动方案，在短期应对能力和长期策略定位之间取得平衡。首先，应实现供应链多元化，并评估区域组装和本地伙伴关係的机会，以降低贸易政策波动带来的风险，并缩短关键备件的前置作业时间。这种务实的做法将增强服务的连续性，并在不同的支付方环境下提供灵活的采购方式。

其次，需要投资软体和分析能力，以增强影像量化、工作流程自动化和远端服务诊断。这些能力不仅能提高诊断的一致性，还能透过服务订阅和平台货币化创造持续价值。第三，透过预防性保养计画、延长保固期和基于绩效的服务协议来扩展服务范围，使供应商的奖励与临床运转率和影像品质挂钩。

第四，我们将推动示踪剂和研究合作，拓展临床应用范围，超越传统药物，并支持治疗诊断学计画和特殊影像需求。第五，我们将开发符合当地实际情况的商业模式，提供模组化融资、行动部署方案和培训项目，以提升本地临床能力。最后，我们将积极与监管机构和支付方沟通，使实证医学方案与报销预期和品质框架保持一致，确保顺利实施并实现持续的临床疗效。

本报告所依据的研究综合采用了一种透明的混合方法研究方法，结合了初步访谈、技术审查、监管分析和交叉检验，以确保提供可靠的实用见解。

本报告的研究综合基于混合方法，强调对主要研究结果、技术文献和监管文件进行三角验证。主要研究包括对临床负责人、影像物理学家、服务经理和采购专业人员进行结构化访谈，以了解不同医疗机构在营运方面面临的挑战、技术优先事项和决策标准。这些定性研究结果辅以设备层面的技术评估、同行评审的出版物和公开的监管文件，以检验性能特征和合规途径。

辅助证据收集包括分析临床试验註册库、审查示踪剂开发平臺以及查阅会议论文，以了解新兴应用和技术趋势。在适用情况下，我们使用匿名案例研究和营运审核结果来评估安装实务、维护结构和服务模式的有效性。在整个过程中，我们采用专家交叉检验来确保准确性并发现不同的观点。

透过敏感性分析和方法论保障措施，识别并解决了研究限制。数据品管包括资讯来源检验、同侪审查决策以及对推断性结论的清晰审核追踪。调查方法强调透明度和可重复性，使客户对研究结果的可靠性和情境相关性充满信心，从而支持其策略决策。

一项综合性研究，将技术进步、服务模式和政策趋势连结起来，从而得出优化PET-CT应用、临床价值和韧性的策略要务。

本执行摘要提供的综合分析表明，PET-CT 仍然是一项重要的诊断和研究工具，其策略价值因近期技术和组织变革而得到提升。检测器技术、重建演算法和软体驱动工作流程的创新正在提高诊断和营运效率，而不断发展的示踪剂格局和混合临床模式正在拓展该技术的临床应用范围。同时，贸易政策的波动以及采购、监管和基础设施的区域差异，也带来了独特的营运挑战和策略机会。

对于相关人员，至关重要的是要进行观点思考，协调产品设计与服务交付，建立能够降低外部衝击风险的供应链，并投资于能够创造持久价值的软体和临床伙伴关係。这将使製造商、供应商和经销商能够确保PET-CT技术既能改善患者预后，又能实现可预测的营运绩效。本报告的洞见和建议旨在为资本配置、产品蓝图和合作策略提供参考，从而塑造PET-CT技术应用和临床整合的下一阶段。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧和深度学习演算法整合到PET-CT成像工作流程中，以提高癌症患者的诊断准确性
  • 开发和商业化一种全身PET-CT系统，该系统能够以高灵敏度和短扫描时间提供动态全身成像。
  • PET-CT是一种用于免疫PET应用的新型放射性追踪剂，能够即时监测癌症免疫治疗反应。
  • 携带式、小型设备的出现使得照护现场分子成像成为可能，即使在农村地区和医疗资源有限的机构也是如此。
  • 透过对现有PET-CT系统进行改造，加装硅光电倍增器检测器，以提高空间解析度和定量精度。
  • 监管部门的核准和报销政策的变化正在加速亚太和拉丁美洲医疗保健市场对 PET-CT 的采用。
  • 与影像诊断中心和放射性药物生产商合作，开发用于治疗诊断应用的个人化PET-CT通讯协定
  • 利用创新示踪剂拓展PET-CT的临床应用：从肿瘤学到神经学和心血管疾病诊断
  • 将PET-CT数据与先进的放射组学和精准医学平台结合，用于癌症治疗计划的预测分析。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 PET-CT扫描仪市场依应用领域划分

  • 心臟病学
  • 神经病学
  • 肿瘤学
    • FDG示踪剂
    • 非FDG示踪剂

9. PET-CT扫描仪市场（依设备类型划分）

  • 固定的
  • 移动的

第十章 PET-CT扫描仪市场（按最终用户划分）

  • 诊断中心
  • 医院
    • 私立医院
    • 公立医院
  • 研究所

第十一章 依服务类型分類的PET-CT扫描仪市场

  • 安装
  • 维护
  • 升级

第十二章 PET-CT扫描仪市场（依机架类型划分）

  • 多切面
  • 单切片

第十三章 PET-CT扫描仪市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 PET-CT扫描仪市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国PET-CT扫描仪市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • General Electric Company
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • United Imaging Healthcare Co., Ltd.
    • Neusoft Corporation
    • Hitachi, Ltd.
    • Shimadzu Corporation
    • Analogic Corporation
    • Fujifilm Holdings Corporation
Product Code: MRR-521BAA36EA75

The PET-CT Scanners Market is projected to grow by USD 4.27 billion at a CAGR of 5.31% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.82 billion
Estimated Year [2025] USD 2.97 billion
Forecast Year [2032] USD 4.27 billion
CAGR (%) 5.31%

A strategic orientation to PET-CT imaging that frames its clinical relevance, technological evolution, and implications for procurement and service delivery within healthcare systems

Positron emission tomography-computed tomography (PET-CT) has evolved into a cornerstone imaging modality, uniquely positioned at the intersection of functional and anatomical diagnostics. Its capacity to visualize metabolic activity alongside morphological detail underpins crucial clinical pathways across oncology, cardiology, and neurology, while supporting research and theranostic applications. Beyond clinical value, PET-CT systems shape workflows, capital planning, and service models for hospitals, diagnostic centers, and research institutions.

Technological progress in detector materials, image reconstruction algorithms, and integrated software platforms has enhanced image fidelity, scan speed, and quantitative accuracy. These advances, together with growing interest in novel radiotracers and hybrid diagnostic-therapeutic protocols, have redefined expectations for diagnostic yield and patient throughput. As a result, stakeholders must navigate a more complex procurement landscape where device capabilities, tracer ecosystems, and service commitments converge to influence clinical and economic outcomes.

In this context, strategic decision-making requires a holistic view that encompasses device architecture, gantry performance, service and upgrade pathways, and end-user operational needs. The subsequent sections synthesize transformative shifts affecting technology adoption, trade-policy headwinds, segmentation nuances, regional dynamics, competitive imperatives, and actionable steps for leaders. The aim is to provide a structured narrative that supports informed choices across clinical, financial, and regulatory domains.

How detector innovation, AI-enabled software, evolving tracer ecosystems, and new deployment models are jointly reshaping clinical workflows, procurement, and service strategies

The landscape for PET-CT systems is undergoing several convergent shifts that are transforming clinical workflows, supply chains, and commercialization strategies. Rapid improvements in detector sensitivity and reconstruction techniques are enabling shorter scan times and finer lesion detectability, yielding tangible workflow efficiencies and diagnostic confidence. Concurrently, software-driven advancements-particularly in artificial intelligence and quantitative imaging-are increasing the value of integrated platforms that offer decision support, automated quality control, and streamlined reporting.

On the operational front, healthcare providers are evaluating new deployment models that balance fixed installations with mobile or decentralized services to reach underserved populations and optimize scanner utilization. This transition is reinforced by a growing emphasis on service contracts, remote diagnostics, and preventive maintenance programs that preserve uptime and extend asset life. At the same time, the tracer ecosystem is diversifying: while established radiotracers remain central, research into non-FDG agents and theranostic pairs is accelerating, prompting closer collaboration between device manufacturers, radiopharmaceutical suppliers, and clinical teams.

Finally, regulatory expectations and reimbursement frameworks are evolving to address quality assurance, data governance, and value-based care. These changes are encouraging vendors and providers to prioritize interoperable systems, robust documentation, and outcomes-oriented evidence generation. Taken together, these transformative shifts are elevating the role of integrated technology-service partnerships and strategic planning in shaping how PET-CT capabilities are acquired, deployed, and sustained.

Assessing how recent tariff adjustments have altered sourcing economics, supply chain resilience, and procurement strategies for imaging hardware and critical components

The cumulative impact of tariff changes imposed by a major economy has created a set of operational and strategic effects that stakeholders must weigh carefully. Increased import duties on imaging hardware and components typically result in higher landed costs for end users, prompting procurement teams to reassess total cost of ownership considerations and to explore alternative sourcing strategies. As tariffs render some supply routes less economical, manufacturers and suppliers may accelerate localization of manufacturing, diversify sourcing footprints, or reconfigure component sourcing to mitigate exposure to trade barriers.

Beyond immediate cost implications, tariff-driven shifts can introduce friction into existing supply chains, generating longer lead times for critical spare parts and replacement modules. This risk underscores the importance of service resilience and inventory planning for providers that rely on rapid access to components to maintain clinical continuity. Moreover, regulatory compliance and customs procedures can add administrative burden to cross-border transactions, influencing contract terms, warranty structures, and the negotiation of service-level agreements.

In response, stakeholders tend to recalibrate procurement strategies, increase emphasis on modular designs that facilitate local assembly or repair, and strengthen partnerships with regional distributors and service providers. Concurrently, there is a tendency to prioritize devices with lower import intensity or to leverage financing mechanisms that smooth capital expenditure impacts. Taken together, these adaptations demonstrate how trade policy shocks propagate across the ecosystem, affecting capital decisions, service reliability, and the pace at which new technologies are adopted.

Segmentation-driven insights that connect clinical applications, device typologies, end-user requirements, service modalities, and gantry architectures to strategic decision-making

A nuanced understanding of product and service segmentation is essential to align technology offerings with clinical use cases and institutional capabilities. In terms of clinical application, cardiology, neurology, and oncology represent distinct demand drivers; oncology remains particularly dynamic, with differentiation between FDG-based imaging that supports broad metabolic assessment and non-FDG tracers that target specific biological pathways or receptor profiles. These application-level distinctions influence scanner selection criteria, tracer logistics, and the design of imaging protocols.

Device type considerations further refine deployment decisions. Fixed systems typically serve high-volume centers where throughput and comprehensive functionality are priorities, while mobile units provide flexibility for outreach programs and shared-service arrangements among smaller institutions. End-user diversity matters as well: diagnostic centers prioritize throughput and ease of scheduling, hospitals balance inpatient and outpatient workflows and may require integrated electronic health record connectivity, and research institutes value modularity and advanced quantitative capabilities. Within hospital settings, private facilities often emphasize customer experience and value-added service agreements, whereas public hospitals focus on cost-effectiveness and broad access.

Service type choices-installation, maintenance, and upgrades-determine long-term performance and lifecycle economics. Proactive maintenance regimes and structured upgrade paths can extend useful life and preserve image quality, while installation quality affects initial calibration and regulatory compliance. Gantry architecture, whether multi-slice or single-slice, has implications for spatial resolution, scan time, and compatibility with advanced reconstruction techniques. Integrating these segmentation lenses yields a comprehensive foundation for matching product roadmaps and service models to market needs.

Regional nuances across the Americas, Europe-Middle East-Africa, and Asia-Pacific that shape procurement preferences, service models, and tracer logistics across diverse healthcare systems

Regional dynamics create varied demand characteristics and operational considerations that influence how stakeholders prioritize investment and deployment. In the Americas, healthcare systems display a wide spectrum of payer models and capital financing approaches, and large tertiary centers often act as early adopters of advanced imaging modalities. As a result, emphasis is placed on integrated workflows, robust service networks, and compatibility with a range of radiotracers to support complex oncologic, neurologic, and cardiac imaging programs.

The Europe, Middle East & Africa region encompasses diverse regulatory environments and procurement modalities, driving a need for adaptable commercial strategies. In several markets, publicly funded health systems prioritize cost-effective solutions and long-term maintenance agreements, while private centers compete on service differentiation and rapid access. Cross-border collaboration and regional distribution partnerships are common approaches to address logistical challenges and to ensure continuity of tracer supply in markets with limited cyclotron infrastructure.

Asia-Pacific presents a broad mix of rapidly expanding capacity and technology adoption alongside mature centers of excellence. High population density in large metropolitan areas creates demand for scalable solutions, including mobile deployments to extend access to peripheral regions. Additionally, local manufacturing initiatives and strategic alliances between global vendors and regional partners are influencing product localization, regulatory submission timelines, and aftermarket service models. Understanding these regional nuances is essential for aligning product offerings and service footprints with on-the-ground operational realities.

How competitive advantage is shifting toward integrated platforms that combine hardware performance, software intelligence, service excellence, and strategic tracer partnerships

Competitive dynamics are increasingly defined by the interplay between hardware innovation, software ecosystems, and service excellence. Leading suppliers pursue strategies that combine platform performance with scalable software solutions that enable quantitative imaging, workflow automation, and remote diagnostics. Partnerships with radiopharmaceutical suppliers and research institutions are becoming central to differentiated value propositions, enabling tailored tracer-support programs and clinical evidence generation that reinforce diagnostic positioning.

Service and aftermarket offerings represent a growing revenue and differentiation vector. Extended warranties, performance-based service contracts, and remote-monitoring capabilities are being positioned to reduce downtime and provide predictable lifecycle economics for providers. At the same time, modular hardware architectures and upgrade pathways help vendors preserve installed-base relationships while offering incremental feature improvements without complete system replacement.

Collaborative commercialization models-ranging from joint ventures to localized manufacturing and distribution agreements-help vendors address tariff exposures and regulatory complexities in target markets. In parallel, some companies are investing in training and accreditation programs for clinical teams to support advanced protocols and novel tracers, thereby accelerating clinical adoption. Together, these strategic moves indicate that competitive advantage increasingly hinges on integrated solutions that combine technical excellence with service depth, regulatory insight, and clinical partnership.

Practical, prioritized recommendations for manufacturers, providers, and distributors to strengthen supply resilience, expand service value, and accelerate clinical adoption of PET-CT technologies

To capture both clinical impact and commercial value, industry leaders should adopt a set of pragmatic, prioritized actions that balance near-term resilience with long-term positioning. First, diversify supply chains and evaluate opportunities for regional assembly or local partnerships to reduce exposure to trade-policy disruptions and to shorten lead times for critical spares. This pragmatic approach will strengthen service continuity and provide procurement flexibility across different payer environments.

Second, invest in software and analytics capabilities that enhance image quantitation, workflow automation, and remote service diagnostics. These capabilities not only improve diagnostic consistency but also create recurring value through service subscriptions and platform monetization. Third, expand service footprints through preventive maintenance programs, extended warranties, and outcome-oriented service contracts that align vendor incentives with clinical uptime and image quality.

Fourth, pursue tracer and research collaborations to broaden clinical applications beyond conventional agents, supporting theranostic programs and specialty imaging needs. Fifth, tailor commercial models to regional realities by offering modular financing, mobile deployment options, and training programs that build local clinical capacity. Finally, engage proactively with regulators and payers to align evidence generation plans with reimbursement expectations and quality frameworks, ensuring smoother adoption pathways and sustained clinical impact.

A transparent, mixed-methods research approach that blends primary interviews, technical reviews, regulatory analysis, and cross-validation to ensure robust, actionable insights

The research synthesis underpinning this report is grounded in a mixed-methods approach that emphasizes triangulation of primary insights, technical literature, and regulatory documentation. Primary research included structured interviews with clinical leaders, imaging physicists, service managers, and procurement specialists to elicit operational challenges, technology priorities, and decision criteria across diverse care settings. These qualitative inputs were complemented by device-level technical reviews, peer-reviewed publications, and public regulatory filings to validate performance attributes and compliance pathways.

Secondary evidence streams involved analysis of clinical trial registries, tracer development pipelines, and conference proceedings to capture emerging applications and technology directions. Where applicable, anonymized case studies and operational audits informed assessments of installation practices, maintenance regimes, and service model efficacy. Throughout the process, findings were cross-validated with subject-matter experts to ensure accuracy and to surface divergent perspectives.

Limitations were acknowledged and addressed through sensitivity checks and methodological safeguards. Data quality controls included source verification, reviewer adjudication, and a clear audit trail for inferential claims. The methodology emphasizes transparency and reproducibility, providing clients with confidence in the reliability of the insights and the contextual relevance for strategic decision-making.

Concluding synthesis that links technological advances, service models, and policy dynamics to strategic imperatives for optimizing PET-CT deployment, clinical value, and resilience

The synthesis presented throughout this executive summary underscores that PET-CT remains a critical diagnostic and research tool whose strategic value is amplified by recent technological and organizational shifts. Innovations in detector technology, reconstruction algorithms, and software-driven workflow enhancements are increasing diagnostic yield and operational efficiency, while evolving tracer landscapes and hybrid clinical paradigms expand the modality's clinical footprint. At the same time, trade-policy perturbations and regional nuances in procurement, regulation, and infrastructure create differentiated operational challenges and strategic opportunities.

For stakeholders, the imperative is to think holistically: align product design with service offerings, build supply chains that reduce exposure to external shocks, and invest in software and clinical partnerships that generate sustained value. By doing so, manufacturers, providers, and distributors can ensure that PET-CT capabilities deliver both improved patient outcomes and predictable operational performance. The insights and recommendations in this report are intended to inform capital allocation, product roadmaps, and collaborative strategies that will shape the next phase of PET-CT adoption and clinical integration.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence and deep learning algorithms into PET-CT imaging workflows to enhance diagnostic accuracy in oncology patients
  • 5.2. Development and commercialization of total-body PET-CT systems offering whole-body dynamic imaging with high sensitivity and reduced scan times
  • 5.3. Adoption of novel radiotracers in PET-CT for immunoPET applications to monitor cancer immunotherapy response in real time
  • 5.4. Emergence of portable and compact PET-CT scanners enabling point-of-care molecular imaging in rural and underserved healthcare facilities
  • 5.5. Retrofitting existing PET-CT systems with silicon photomultiplier detectors to improve spatial resolution and quantitative accuracy
  • 5.6. Regulatory approvals and reimbursement policy changes accelerating PET-CT adoption in Asia Pacific and Latin American healthcare markets
  • 5.7. Collaborations between imaging centers and radiopharmaceutical companies to develop personalized PET-CT protocols for theranostic applications
  • 5.8. Expansion of PET-CT clinical applications beyond oncology into neurology and cardiovascular disease diagnostics through innovative tracers
  • 5.9. Integration of PET-CT data with advanced radiomics and precision medicine platforms for predictive analytics in cancer treatment planning

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PET-CT Scanners Market, by Application

  • 8.1. Cardiology
  • 8.2. Neurology
  • 8.3. Oncology
    • 8.3.1. FDG Tracer
    • 8.3.2. Non-FDG Tracer

9. PET-CT Scanners Market, by Device Type

  • 9.1. Fixed
  • 9.2. Mobile

10. PET-CT Scanners Market, by End User

  • 10.1. Diagnostic Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Research Institutes

11. PET-CT Scanners Market, by Service Type

  • 11.1. Installation
  • 11.2. Maintenance
  • 11.3. Upgrades

12. PET-CT Scanners Market, by Gantry Type

  • 12.1. Multi-Slice
  • 12.2. Single-Slice

13. PET-CT Scanners Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. PET-CT Scanners Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. PET-CT Scanners Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. General Electric Company
    • 16.3.2. Siemens Healthineers AG
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Canon Medical Systems Corporation
    • 16.3.5. United Imaging Healthcare Co., Ltd.
    • 16.3.6. Neusoft Corporation
    • 16.3.7. Hitachi, Ltd.
    • 16.3.8. Shimadzu Corporation
    • 16.3.9. Analogic Corporation
    • 16.3.10. Fujifilm Holdings Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PET-CT SCANNERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PET-CT SCANNERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PET-CT SCANNERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PET-CT SCANNERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PET-CT SCANNERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. GCC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GCC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GCC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GCC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. GCC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 274. GCC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 275. GCC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. GCC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. GCC PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GCC PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. GCC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 280. GCC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 281. GCC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. GCC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. GCC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GCC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. BRICS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 312. BRICS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. G7 PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. G7 PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. G7 PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. G7 PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. G7 PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 322. G7 PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 323. G7 PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. G7 PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. G7 PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. G7 PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. G7 PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 328. G7 PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 329. G7 PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. G7 PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. G7 PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. NATO PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. NATO PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. NATO PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 336. NATO PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 337. NATO PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 338. NATO PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 339. NATO PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. NATO PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. NATO PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. NATO PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. NATO PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 344. NATO PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 345. NATO PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. NATO PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. NATO PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. NATO PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025-2032 (USD MILLION)
  • TABLE 349. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 350. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 351. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 353. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 354. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 355. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 356. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 357. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 358. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 359. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 360. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 361. UNITED STATES PET